2020
DOI: 10.11604/pamj.2020.36.46.23561
|View full text |Cite
|
Sign up to set email alerts
|

Congenital Factor V deficiency: perioperative management (case report)

Abstract: Factor V congenital deficiency is a rare hereditary disease, it exposes patients to hemorrhagic risk, with high morbi-mortality. Its management is a real challenge for practitioners. Perioperative management of patients with Factor V congenital deficiency needs anesthetists, hematologists and surgeons to work in close collaboration.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 4 publications
0
1
0
Order By: Relevance
“…FV-deficient patients have low plasma levels of the anticoagulant protein tissue factor pathway inhibitor, which considerably reduces the FV requirement for thrombin generation [ 1 ], so it is thought that FⅤ in platelet α-granules alone can produce sufficient amounts of thrombin for hemostasis [ 1 , 11 , 12 ]. Some reports suggest that the severity of bleeding depends on the FⅤ levels in platelets [ 2 ]. Thus, coagulation factors and platelets play an important role in the perioperative management of patients with FⅤ deficiency.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…FV-deficient patients have low plasma levels of the anticoagulant protein tissue factor pathway inhibitor, which considerably reduces the FV requirement for thrombin generation [ 1 ], so it is thought that FⅤ in platelet α-granules alone can produce sufficient amounts of thrombin for hemostasis [ 1 , 11 , 12 ]. Some reports suggest that the severity of bleeding depends on the FⅤ levels in platelets [ 2 ]. Thus, coagulation factors and platelets play an important role in the perioperative management of patients with FⅤ deficiency.…”
Section: Discussionmentioning
confidence: 99%
“…Most patients with this disorder present with mild to moderate bleeding symptoms and rarely require transfusion of blood products or hemostatic intervention [ 1 ]. However, under highly invasive circumstances such as trauma or surgical procedures (including tooth extraction), even patients with mild bleeding symptoms may be susceptible to abnormal bleeding [ 2 , 3 ], and FⅤ activity should be maintained above 15%-25% in the perioperative period [ 4 , 5 ]. In Japan, where recombinant FⅤ products are currently unavailable, fresh frozen plasma (FFP) has been used when supplementation is required [ 4 ].…”
Section: Introductionmentioning
confidence: 99%
“…Transfusion of FFP and maintenance of factor level between 15% and 20% throughout the perioperative period is imperative to prevent hemorrhagic accidents during surgical procedures. [ 14 ] Postoperative daily screening for factor level is advisable for moderation of FFP transfusion and surveillance. The management strategy employed in our case involved transfusion of FFP to proactively address the deficiency and elevate the factor V level above 20%, followed by administration of another additional unit of FFP 1 h before surgery to further bolster the factor levels and reduce the likelihood of intraoperative bleeding.…”
Section: Discussionmentioning
confidence: 99%
“…Upon FFP transfusion, symptoms are milder and more asymptomatic than those in case of hemophilia; the risk of death associated with bleeding events is low, and the prognosis is good [ 7 ]. There are multiple reports of FFP transfusion for surgeries, such as heart surgery [ 8 ], cochlear implant surgery [ 9 ], intracranial drainage for chronic subdural hematoma [ 10 ], laparoscopic-assisted vaginal hysterectomy, bilateral salpingo-oophorectomy [ 11 ], and laparoscopic cholecystectomy [ 12 ]. In this case, surgery or RFA was considered for treatment based on the BCLC staging algorithm [ 13 ].…”
Section: Discussionmentioning
confidence: 99%